MNOV
Income statement / Annual
Last year (2023), MediciNova, Inc.'s total revenue was $1.00 M,
and the percentage change from the previous year is not available.
In 2023, MediciNova, Inc.'s net income was -$8.57 M.
See MediciNova, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$1.00 M
|
$0.00
|
$4.04 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$20,295.00 |
$212,426.00 |
$0.00 |
$21,342.00 |
$23,944.00 |
$25,881.00 |
$28,098.00 |
$14,127.00 |
$26,704.00 |
$0.00 |
| Gross Profit |
$979,705.00 |
-$212,426.00 |
$4.04 M |
-$21,342.00 |
-$23,944.00 |
-$25,881.00 |
-$28,098.00 |
-$14,127.00 |
-$26,704.00 |
$0.00 |
| Gross Profit Ratio |
0.98 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.66 M
|
$9.14 M
|
$8.54 M
|
$7.48 M
|
$6.08 M
|
$5.63 M
|
$4.22 M
|
$3.52 M
|
$3.02 M
|
$3.26 M
|
| General & Administrative
Expenses |
$4.98 M
|
$5.48 M
|
$5.72 M
|
$6.69 M
|
$7.95 M
|
$9.96 M
|
$8.80 M
|
$7.36 M
|
$5.81 M
|
$5.96 M
|
| Selling & Marketing
Expenses |
$257,931.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.24 M
|
$5.48 M
|
$5.72 M
|
$6.69 M
|
$7.95 M
|
$9.96 M
|
$8.80 M
|
$7.36 M
|
$5.81 M
|
$5.96 M
|
| Other Expenses |
$0.00 |
-$247,285.00 |
-$59,498.00 |
-$38,404.00 |
-$46,163.00 |
-$22,894.00 |
$120,205.00 |
$20,063.00 |
-$14,820.00 |
$24,375.00 |
| Operating Expenses |
$10.90 M |
$14.63 M |
$14.25 M |
$14.18 M |
$14.03 M |
$15.59 M |
$13.03 M |
$10.88 M |
$8.82 M |
$9.22 M |
| Cost And Expenses |
$10.90 M |
$14.63 M |
$14.25 M |
$14.18 M |
$14.03 M |
$15.59 M |
$13.03 M |
$10.88 M |
$8.82 M |
$9.22 M |
| Interest Income |
$1.83 M |
$809,673.00 |
$143,626.00 |
$361,182.00 |
$1.15 M |
$939,909.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$298.00 |
$454.00 |
$514.00 |
$628.00 |
| Depreciation &
Amortization |
$20,295.00
|
$212,426.00
|
$26,149.00
|
$21,342.00
|
$23,944.00
|
$25,881.00
|
$28,098.00
|
$14,127.00
|
$26,704.00
|
$40,186.00
|
| EBITDA |
-$9.88 M
|
-$13.85 M
|
-$10.19 M
|
-$14.16 M
|
-$14.01 M
|
-$15.56 M
|
-$13.00 M
|
-$10.87 M
|
-$8.80 M
|
-$9.18 M
|
| EBITDA Ratio |
-9.88 |
0 |
-2.52 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-9.9
|
0
|
-2.53
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.33 M
|
$562,388.00
|
$84,128.00
|
$322,778.00
|
$1.10 M
|
$917,015.00
|
$119,907.00
|
$19,609.00
|
-$15,334.00
|
$23,747.00
|
| Income Before Tax |
-$8.57 M |
-$14.07 M |
-$10.13 M |
-$13.86 M |
-$12.93 M |
-$14.67 M |
-$12.91 M |
-$10.86 M |
-$8.84 M |
-$9.20 M |
| Income Before Tax Ratio
|
-8.57
|
0
|
-2.51
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$3,047.00 |
$2,822.00 |
$2,568.00 |
-$1,648.00 |
$12,660.00 |
$5,276.00 |
-$1.74 M |
$3,754.00 |
$7,359.00 |
-$3,972.00 |
| Net Income |
-$8.57 M |
-$14.07 M |
-$10.13 M |
-$13.85 M |
-$12.94 M |
-$14.68 M |
-$11.16 M |
-$10.87 M |
-$8.85 M |
-$9.20 M |
| Net Income Ratio |
-8.57 |
0 |
-2.51 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.17 |
-0.29 |
-0.21 |
-0.31 |
-0.3 |
-0.36 |
-0.32 |
-0.33 |
-0.33 |
-0.38 |
| EPS Diluted |
-0.17 |
-0.29 |
-0.21 |
-0.31 |
-0.3 |
-0.36 |
-0.32 |
-0.33 |
-0.33 |
-0.38 |
| Weighted Average Shares
Out |
$49.05 M
|
$49.05 M
|
$48.60 M
|
$44.41 M
|
$43.16 M
|
$41.12 M
|
$35.14 M
|
$32.99 M
|
$26.58 M
|
$24.07 M
|
| Weighted Average Shares
Out Diluted |
$49.05 M
|
$49.05 M
|
$48.60 M
|
$44.41 M
|
$43.16 M
|
$41.12 M
|
$35.14 M
|
$32.99 M
|
$26.58 M
|
$24.07 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
